BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:12 PM
 | 
Nov 18, 2009
 |  BC Extra  |  Politics & Policy

Novartis, MedImmune cite FDA vaccine hurdles

Novartis AG (NYSE:NVS; SIX:NOVN) and AstraZeneca plc (LSE:AZN; NYSE:AZN) subsidiary MedImmune said on Wednesday that FDA regulatory requirements have prevented them from introducing influenza vaccine technologies in the U.S. that are used in...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >